To buy shares in ImmuCell Corporation you will need a US based stock trading platform like Interactive Brokers, eToro or Moomoo where it currently costs $5.54 to buy one share in ImmuCell Corporation (as of 16:00 20-May-2025). Which is a change of $0.02 or 0.36% from the last closing price of $5.52.
How To Buy ImmuCell Corporation Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in ImmuCell Corporation:
- Pick a stock broker (jump down to compare the best brokers for buying ImmuCell Corporation stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:ICCC)
- Choose the number of shares you want to buy (1 share currently costs $5.54)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your ImmuCell Corporation stock in your account (this will show your profit and loss)
ImmuCell Corporation Share Price (ICCC) Quote & Overview
This section shows the most important aspects of the current ImmuCell Corporation ICCC:US share price including price, change, bid/offer spread and volume.
- ImmuCell Corporation is currently worth $50,067,179 based on the last closing price of $5.52 with 22,827 shares traded.
- The most recent ImmuCell Corporation daily high has been $5.58 and daily low $5.42.
- The ImmuCell Corporation stock price 52 week high has been $5.72 and the 52 week low $3.35.
Compare Brokers For Buying ImmuCell Corporation Stock
It’s usually commission-free to buy US stocks as American stock brokers make their money from payment for order flow. However, there can sometimes be additional charges for buying stocks in an IRA, where your contributions are tax-deductible.
| US Stock Broker | US Stocks Available | Dealing Commission | Margin Rates | Customer Reviews | More Info |
|---|---|---|---|---|---|
 | 17,913 | 0.003% | 5.33% – 6.33% | (Based on 934 reviews)
| Visit Broker Your capital is at risk |
 | 6,000+ | 0% | 0% | (Based on 144 reviews)
| Visit Broker Your capital is at risk |
 | 5,000+ | 0% | 8% – 11% | (Based on 0 reviews)
| Read Reviews |
 | 4,000+ | 0% | 10.2% – 13.2% | (Based on 1 reviews)
| Read Reviews |
 | 4,000+ | 0% | 8.575% – 13.075% | (Based on 22 reviews)
| Read Reviews |
 | 5,000+ | 0% | 8% (Flat) | (Based on 23 reviews)
| Read Reviews |
 | 7,000+ | 0% | 8.5% – 12.075% | (Based on 0 reviews)
| Read Reviews |
 | 5,000+ | 0% | 9.49% (Flat) | (Based on 0 reviews)
| Read Reviews |
Is Now A Good Time To Buy ImmuCell Corporation Stock?
For expert analysis join Good Money Guide Premium.
- ImmuCell Corporation’s EPS (earnings per share) are 0.06. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- ImmuCell Corporation’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below ImmuCell Corporation share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.
ImmuCell Corporation (ICCC) Analysis
This section shows analysis for ImmuCell Corporation ICCC:US. It shows analyst rating, recommnedations and history, as well industry ranking comparison.
ImmuCell Corporation (ICCC) Earnings Estimates & Forecasts
This section shows how analysts expect the ImmuCell Corporation ICCC:US share price to perform in the future based on their earnings reports and estimates. It gives an overview of future short, long and medium term price targets as well as previous earnings reports.
ImmuCell Corporation (ICCC) Company Financials
This section shows current and previous ImmuCell Corporation ICCC:US profit and loss information like revenue, income, expenses and earnings per share.
ImmuCell Corporation (ICCC) Financial Summary
This section allows you to compare ImmuCell Corporation ICCC:US revenue, net income, cash flow statement and balance sheet against previous years. This can give you a good indication of how well a company is performing.
ImmuCell Corporation (ICCC) Share Price History
This section provides a visual and table view of the historic ImmuCell Corporation ICCC:US share price including volume and VWAP which can be adjusted for splits and dividends.
ImmuCell Corporation (ICCC) Interactive Chart
This section allows you to compare ImmuCell Corporation ICCC:US share price chart against other stocks as well as overlay key events like dividends, earnings and splits.
ImmuCell Corporation (ICCC) Dividends
This section analyses the historic and upcoming ImmuCell Corporation ICCC:US dividend amounts, dates and yields. It provides a good indication of potential future and past profitability.
ImmuCell Corporation (ICCC) Corporate Events
This section shows key dates in ImmuCell Corporation ICCC:US corporate calendar like company announcements, earnings releases, stock splits, and fundamental data chances like EPS updates.
ImmuCell Corporation (ICCC) Share Price Performance
This section shows key ImmuCell Corporation ICCC:US share price levels like recent highs and lows, plus gives you tools to see average day traded volumes and institutional share holders major buys and sells.
ImmuCell Corporation (ICCC) Share Price News
This section shows new stories that are relevant to and may effect or explain changes in ImmuCell Corporation ICCC:US share price.
ImmuCell Corporation (ICCC) Company Profile
This section provides corporate information on ImmuCell Corporation ICCC:US, including what they do, their contact details, their CEO and auditor as well as in what sectors their shares trade.
